Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001623632-24-001866
Filing Date
2024-11-06
Accepted
2024-11-06 08:54:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 eyepointpharmaceuticals13g.htm SC 13G 106198
2 GRAPHIC image_001.jpg GRAPHIC 60182
3 GRAPHIC image_002.jpg GRAPHIC 69253
  Complete submission text file 0001623632-24-001866.txt   286906
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81613 | Film No.: 241429374
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)